Nikkan Yakugyo Serial Planning "Toward the Era of Co-creation

<1〉Pharmaceutical Industrial Policy Committee	JPMA Chairperson: Iwashita, Industry Policy Chairperson: "Pharmaceuticals should be a growth market, with indicators and calculations. 　　Published in Nikkan Yakugyo, August 29, 2025 [License No. 20250829_01] Jiho Inc. has granted permission to use this article.
<2>Distribution Improvement Committee	Chairperson Kumagai, Chairperson of the Distribution Optimization Committee, explained the reason for one-company distribution. 　　Nikkan Yakugyo, September 1, 2025 [License No. 20250901_02] Jiho Co.
<3>Drug Evaluation Committee	JPMA and Drug Evaluation Committee focus on improving the clinical trial environment in Japan, with international standards in mind 　　Nikkan Yakugyo, September 2, 2025 [License No. 20250902_02] Jiho Co.
4〉Regulatory Affairs Committee	Warning Bells Over Extreme "No Need for Japanese P1," Chairperson Kashitani Urges Correct Understanding of the Purpose 　　Nikkan Yakugyo September 3, 2025 [License No. 20250903_01] Jiho Co.
5〉Environmental Issue Committee	Chairperson of the Environmental Issue Committee, Mr. Arima, to formulate broad-based rules for greenhouse gases. 　　Nikkan Yakugyo September 4, 2025 [License No. 20250904_01] Jiho Co.
(6)ICH Project	ICH-PJ Chairperson Yokota: "RWE can complement clinical trials," hopes for new topics. 　　Nikkan Yakugyo September 5, 2025 [License No. 20250905_01] Jiho Co.
7〉Code Compliance Committee	Revised COP, "Focus on penetration of philosophy," Ouchi, Chairperson of the Code and Compliance Promotion Committee 　　Nikkan Yakugyo September 8, 2025 [License No. 20250908_01] Jiho Co.
Quality & Technology Committee	Chairperson of the Quality Committee, Mr. Kawashima, shares TF and issues in the commercial production DX 　　Nikkan Yakugyo September 9, 2025 [License No. 20250910_06] Jiho Co.
Public Affairs Committee	Public Relations Chairperson Tada Devises a New Way to Communicate Information to Increase Understanding of the Pharmaceutical Industry 　　Nikkan Yakugyo September 10, 2025 [License No. 20250910_01] Jiho Co.
(10)Review Board of Ethical Drug Product Information Brochure	Chairperson Kondo, Review Board of Ethical Drug Product Information Brochure, plans training sessions with medical personnel to develop human resources. 　　Nikkan Yakugyo September 11, 2025 [License No. 20250911_01] Jiho Co.
Consumer Consultation Review Committee	Chairperson of the Pharmaceuticals Consultation Committee, Mr. Wakasugi, "Guideline for handling RWE will be substantially revised this fall. 　　Nikkan Yakugyo September 12, 2025 [License No. 20250912_01] Jiho Co.
12〉Patient Cooperation Committee	Chairperson of the Patient Group Collaboration Promotion Committee, Mr. Misawa, to develop a collection of good examples of "patient/citizen participation. 　　Nikkan Yakugyo September 13, 2025 [License No. 20250917_01] Jiho Co.
Biopharmaceutical Committee	Chairperson of Kurata Biopharmaceuticals Chairperson of Kurata Biopharmaceuticals Chairperson of Kurata Biopharmaceuticals Chairperson of Kurata Biopharmaceuticals Chairperson of Kurata Biopharmaceuticals Chairperson of Kurata Biopharmaceuticals Chairperson of Kurata Biopharmaceuticals Chairperson of Kurata Biopharmaceuticals 　　Nikkan Yakugyo September 17, 2025 [License No. 20250917_02] Jiho Co.
Intellectual Property Committee	Intellectual Property Committee establishes TF to study issues in new fields such as AI. 　　Nikkan Yakugyo September 18, 2025 [License No. 20250919_02] Jiho Co.
International Affairs Committee	International Chairperson Murakami strengthens communication to the international community and establishes a new organization. 　　Nikkan Yakugyo September 19, 2025 [License No. 20250919_03] Jiho Co.
16〉R & D Committee	TPP outline released to help bridge the gap, Chairperson of Research and Development Committee Tsukahara 　　Nikkan Yakugyo September 20, 2025 [License No. 20250930_03] Jiho Co.
The Office of Pharmaceutical Industry Research	Dr. Yamada, Director of Pharmaceutical Industry Policy Institute, contributes to the industry's consideration of issues through evidence 　　Nikkan Yakugyo, September 24, 2025 [License No. 20250930_04] Jiho Co.